Conference Report At BIO 2004, Plenaries and Protests Mark Feldbaum’s Exit | GenomeWeb

In June the annual BIO meeting returned to San Francisco, the city many would call the birthplace of biotechnology, and the pageantry was palpable. The world’s largest representative of the biotech industry was excited about showcasing the field’s accomplishments since 1995, when BIO last held its annual meeting in the city, and the 16,000-odd attendees swarmed the sessions and exhibit hall, drawn from one colorfully extravagant regional pavilion to another.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.